Skip to main content

Advertisement

SpringerLink
Log in

Type-2 cannabinoid receptor regulates proliferation, apoptosis, differentiation, and OPG/RANKL ratio of MC3T3-E1 cells exposed to Titanium particles

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The type-2 cannabinoid receptor (CB2) is expressed in osteoblasts and plays a role in bone metabolism through regulation on bone mass and bone turnover, but the functional importance of CB2 in osteoblasts under Titanium (Ti) stimulation is incompletely understood. This study aimed to investigate the CB2 expression in osteoblasts under Ti stimulation and the effects of CB2 activation on proliferation, apoptosis, differentiation, mineralization, OPG, and RANKL expression of MC3T3-E1 cells exposed to Ti particles. MC3T3-E1 cells were incubated in the presence of Ti particles with or without CB2-specific agonist HU-308 and antagonist SR144528. Ti particles treatment obviously induced the CB2 expression in MC3T3-E1 cells, and reduced the cell survival in a dose- and time-dependent manner (p < 0.05). Addition of HU-308 could dose-dependently alleviate the Ti-induced decrease of cell survival (p < 0.05). The flow cytometry assay showed that comparing with the control group, the apoptosis rate and caspase-3 activity in the Ti group were significantly elevated (p < 0.05), which could be alleviated by HU-308. Moreover, HU-308 effectively attenuated the decrease of cell mineralization capability, alkaline phosphates (ALP) and osteocalcin activity, and increase of OPG/RANKL ratio induced by Ti particles treatment (p < 0.05). These effects were partially counteracted by combined treatment of CB2 antagonist SR144528 (p < 0.05). In conclusion, CB2 activation has a favorable inhibitory effect on Ti-induced reactions in MC3T3-E1 cell through modulating proliferation, apoptosis, differentiation, and RANKL expression. These findings suggest that activation of CB2 might be an effective therapeutic strategy to promote bone formation and reduce bone dissolution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Maloney WJ, Smith RL, Schmalzried TP, Chiba J, Huene D, Rubash H (1995) Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg 77(9):1301–1310

    CAS  PubMed  Google Scholar 

  2. Goodman SB (2007) Wear particles, periprosthetic osteolysis and the immune system. Biomaterials 28(34):5044–5048

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Wooley PH, Schwarz EM (2004) Aseptic loosening. Gene Ther 11(4):402–407

    Article  CAS  PubMed  Google Scholar 

  4. Wedemeyer C, Neuerburg C, Pfeiffer A, Heckelei A, Bylski D, von Knoch F, Schinke T, Hilken G, Gosheger G, von Knoch M, Löer F, Saxler G (2007) Polyethylene particle-induced bone resorption in α-calcitonin gene-related peptide-deficient mice. J Bone Miner Res 22(7):1011–1019

    Article  CAS  PubMed  Google Scholar 

  5. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96(7):3540–3545

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408(6812):600–605

    Article  CAS  PubMed  Google Scholar 

  7. Smith MV, Lee MJ, Islam AS, Rohrer JL, Goldberg VM, Beidelschies MA, Greenfield EM (2007) Inhibition of the PI3K-Akt signaling pathway reduces tumor necrosis factor-α production in response to Titanium particles in vitro. J Bone Joint Surg 89(5):1019–1027

    Article  PubMed  Google Scholar 

  8. Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I (2006) Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA 103(3):696–701

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Ofek O, Attar-Namdar M, Kram V, Dvir-Ginzberg M, Mechoulam R, Zimmer A, Frenkel B, Shohami E, Bab I (2011) CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts. J Bone Miner Res 26(2):308–316

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Sophocleous A, Landao-Bassonga E, van‘t Hof RJ, Idris AI, Ralston SH (2011) The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation. Endocrinology 152(6):2141–2149

  11. Rakshit DS, Ly K, Sengupta TK, Nestor BJ, Sculco TP, Ivashkiv LB, Purdue PE (2006) Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-γ mechanistic insights and implications for periprosthetic osteolysis. J Bone Joint Surg 88(4):788–799

    Article  PubMed  Google Scholar 

  12. Wang W, Ferguson DJ, Quinn JM, Simpson AH, Athanasou NA (1997) Biomaterial particle phagocytosis by bone-resorbing osteoclasts. J Bone Joint Surg 79(5):849–856

    Article  CAS  Google Scholar 

  13. Haleem-Smith H, Argintar E, Bush C, Hampton D, Postma WF, Chen FH, Rimington T, Lamb J, Tuan RS (2012) Biological responses of human mesenchymal stem cells to Titanium wear debris particles. J Orthop Res 30(6):853–863

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Vermes C, Chandrasekaran R, Jacobs JJ, Galante JO, Roebuck KA, Glant TT (2001) The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg 83(2):201–201

    PubMed  Google Scholar 

  15. Schwarz EM, Benz B, Lu AP, Goater JJ, Mollano AV, Rosier RN, Puzas JE, Okeefe RJ (2000) Quantitative small animal surrogate to evaluate drug efficacy in preventing wear debris induced osteolysis. J Orthop Res 18(6):849–855

    Article  CAS  PubMed  Google Scholar 

  16. Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, van Wijnen AJ, Stein JL, Stein GS (2004) Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14(1–2):1–41

    Article  CAS  PubMed  Google Scholar 

  17. Geng D, Xu Y, Yang H, Wang J, Zhu X, Zhu G, Wang X (2010) Protection against Titanium particle induced osteolysis by cannabinoid receptor 2 selective antagonist. Biomaterials 31(8):1996–2000

    Article  CAS  PubMed  Google Scholar 

  18. Whiteside GT, Lee GP, Valenzano KJ (2007) The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists. Curr Med Chem 14(8):917–936

    Article  CAS  PubMed  Google Scholar 

  19. Rossi F, Bellini G, Luongo L, Torella M, Mancusi S, De Petrocellis L, Petrosino S, Siniscalco D, Orlando P, Scafuro M, Colacurci N, Perrotta S, Nobili B, Di Marzo V, Maione S, Endocannabinoid Research Group (ERG), Italy (2011) The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. Bone 48(5):997–1007

  20. Bab I, Ofek O, Tam J, Rehnelt J, Zimmer A (2008) Endocannabinoids and the regulation of bone metabolism. J Neuroendocrinol 20(s1):69–74

    Article  CAS  PubMed  Google Scholar 

  21. Lozano-Ondoua AN, Wright C, Vardanyan A, King T, Largent-Milnes TM, Nelson M, Jimenez-Andrade JM, Mantyh PW, Vanderah TW (2010) A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss. Life Sci 86(17):646–653

    Article  CAS  PubMed  Google Scholar 

  22. Kwon SY, Lin T, Takei H, Ma Q, Wood DJ, O’Connor D, Sung KL (2001) Alterations in the adhesion behavior of osteoblasts by Titanium particle loading: inhibition of cell function and gene expression. Biorheology 38(2):161–183

    CAS  PubMed  Google Scholar 

  23. Pioletti DP, Leoni L, Genini D, Takei H, Du P, Corbeil J (2002) Gene expression analysis of osteoblastic cells contacted by orthopedic implant particles. J Biomed Mater Res 61(3):408–420

    Article  CAS  PubMed  Google Scholar 

  24. Jiang Y, Jia T, Gong W, Wooley PH, Yang SY (2013) Titanium particle-challenged osteoblasts promote osteoclastogenesis and osteolysis in a murine model of periprosthestic osteolysis. Acta Biomater 9(7):7564–7572

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Hanuš L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, Fride E (1999) HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor. Proc Natl Acad Sci USA 96(25):14228–14233

    Article  PubMed Central  PubMed  Google Scholar 

  26. Maoqiang L, Zhenan Z, Fengxiang L, Gang W, Yuanqing M, Ming L, Xin Z, Tingting T (2010) Enhancement of osteoblast differentiation that is inhibited by Titanium particles through inactivation of NFATc1 by VIVIT peptide. J Biomed Mater Res A 95(3):727–734

    Article  PubMed  Google Scholar 

  27. Saleh KJ, Schwarz M (2004) Osteolysis: medical and surgical approaches. Clin Orthop Relat Res 427:138–147

    Article  PubMed  Google Scholar 

  28. Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, Simmons PJ (1999) Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 14(1):47–56

    Article  CAS  PubMed  Google Scholar 

  29. Vermes C, Roebuck KA, Chandrasekaran R, Dobai JG, Jacobs JJ, Glant TT (2000) Particulate wear debris activates protein tyrosine kinases and nuclear factor κB, which down-regulates type I collagen synthesis in human osteoblasts. J Bone Miner Res 15(9):1756–1765

    Article  CAS  PubMed  Google Scholar 

  30. Wang ML, Nesti LJ, Tuli R, Lazatin J, Danielson KG, Sharkey PF, Tuan RS (2002) Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res 20(6):1175–1184

    Article  CAS  PubMed  Google Scholar 

  31. Scutt A, Williamson EM (2007) Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. Calcif Tissue Int 80(1):50–59

    Article  CAS  PubMed  Google Scholar 

  32. Khosla S (2001) Minireview: the OPG/RANKL/RANK system. Endocrinology 142(12):5050–5055

    Article  CAS  PubMed  Google Scholar 

  33. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2):309–319

    Article  CAS  PubMed  Google Scholar 

  34. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423(6937):337–342

    Article  CAS  PubMed  Google Scholar 

  35. Arpinati M, Chirumbolo G, Nicolini B, Agostinelli C, Rondelli D (2009) Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). Bone Marrow Transplant 43(3):253–259

    Article  CAS  PubMed  Google Scholar 

  36. Mine Y, Makihira S, Nikawa H, Murata H, Hosokawa R, Hiyama A, Mimura S (2010) Impact of Titanium ions on osteoblast-, osteoclast- and gingival epithelial-like cells. J Prosthodont Res 54(1):1–6

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by Xuzhou Science and Technology Project (XM13B080).

Conflict of interest

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

  1. Orthopaedic Department of Affiliated Hospital of Xuzhou Medical College, Jiangsu, 223000, China

    Shang Qiu, Fengchao Zhao, Xianye Tang, Fang Pei, Liang Zhu & Kaijin Guo

  2. Institute of Neurobiology, Xuzhou Medical College, Jiangsu, 223000, China

    Hongyan Dong

Authors
  1. Shang Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fengchao Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xianye Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fang Pei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hongyan Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Liang Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kaijin Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kaijin Guo.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qiu, S., Zhao, F., Tang, X. et al. Type-2 cannabinoid receptor regulates proliferation, apoptosis, differentiation, and OPG/RANKL ratio of MC3T3-E1 cells exposed to Titanium particles. Mol Cell Biochem 399, 131–141 (2015). https://doi.org/10.1007/s11010-014-2240-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-014-2240-y

Keywords

Search

Navigation